COMPASS Pathways plc enterprise value

The Enterprise Value as of November 2026 (TTM) for COMPASS Pathways plc (CMPS) is 1.11B

According to COMPASS Pathways plc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.11B. This represents a change of 130.86% compared to the average of 481.99M of the last 4 quarters.

COMPASS Pathways plc (CMPS) Historical Enterprise Value (quarterly & annually)

How has CMPS Enterprise Value performed in the past?

The mean historical Enterprise Value of COMPASS Pathways plc over the last ten years is 499.93M. The current 1.11B Enterprise Value has changed 122.58% with respect to the historical average. Over the past ten years (40 quarters), CMPS's Enterprise Value was at its highest in in the December 2020 quarter at 1.52B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

COMPASS Pathways plc (CMPS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of COMPASS Pathways plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

COMPASS Pathways plc (CMPS) Average Enterprise Value

How has CMPS Enterprise Value performed in the past?

The current Enterprise Value of COMPASS Pathways plc (CMPS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

COMPASS Pathways plc (CMPS) Enterprise Value vs. Peers

How is CMPS’s Enterprise Value compared to its peers?

COMPASS Pathways plc’s Enterprise Value is greater than MapLight Therapeutics, Inc. (236.35M), less than Rapport Therapeutics, Inc. Common Stock (1.13B), less than Mind Medicine (MindMed) Inc. (3.92B), less than Harmony Biosciences Holdings, Inc. (1.84B), greater than Minerva Neurosciences, Inc. (91.33M), greater than LB Pharmaceuticals Inc Common Stock (965.21M), greater than GH Research PLC (1.04B), less than Acadia Pharmaceuticals Inc. (3.20B), less than Praxis Precision Medicines, Inc. (7.25B), less than Denali Therapeutics Inc. (2.79B),

Build a custom stock screener for COMPASS Pathways plc (CMPS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like COMPASS Pathways plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

COMPASS Pathways plc (CMPS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like COMPASS Pathways plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.